✦ LIBER ✦

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial

✍ Scribed by Conroy, Thierry; Galais, Marie-Pierre; Raoul, Jean-Luc; Bouché, Olivier; Gourgou-Bourgade, Sophie; Douillard, Jean-Yves; Etienne, Pierre-Luc; Boige, Valérie; Martel-Lafay, Isabelle; Michel, Pierre; Llacer-Moscardo, Carmen; François, Eric; Créhange, Gilles; Abdelghani, Meher Ben; Juzyna, Beata; Bedenne, Laurent; Adenis, Antoine

Book ID: 121524877
Publisher: The Lancet
Year: 2014
Tongue: English
Weight: 251 KB
Volume: 15
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(14)70028-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Definitive chemoradiotherapy with FOLFOX

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial

✍ Conroy, Thierry; Galais, Marie-Pierre; Raoul, Jean-Luc; Bouché, Olivier; Gourgou 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 251 KB

Preoperative chemoradiotherapy and posto

Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial

✍ Claus Rödel; Torsten Liersch; Heinz Becker; Rainer Fietkau; Werner Hohenberger; 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 218 KB

3502 ORAL Final results of a randomized

3502 ORAL Final results of a randomized phase III trial in patients with advanced adenocarcinoma of the stomach receiving first-line chemotherapy with fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP)

✍ S.E. Al-Batran; J.T. Hartmann; S. Probst; R. Hofheinz; J. Stoehlmacher; C. Pauli 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Randomised phase III trial of adjuvant c

Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: Final results of JCOG0205

✍ Shimada, Yasuhiro; Hamaguchi, Tetsuya; Mizusawa, Junki; Saito, Norio; Kanemitsu, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 582 KB

Efficacy and safety of bevacizumab-based

Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)

✍ Ducreux, M.; Adenis, A.; Pignon, J.-P.; François, E.; Chauffert, B.; Ichanté, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 602 KB

Efficacy and safety of canagliflozin ver

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

✍ Cefalu, William T; Leiter, Lawrence A; Yoon, Kun-Ho; Arias, Pablo; Niskanen, Leo 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 489 KB